Predictive Oncology Inc. (POAI) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 3.62K | 2.68K | 110.31K | 611.59K | 345.69K | 278.72K | 419.65K | 335.03K | 676.63K | 490.11K | 239.9K | 363.47K |
| Revenue Growth % | -98.95% | -99.04% | -73.71% | 82.55% | -48.91% | -43.13% | 74.93% | -7.82% | 48.44% | 31.89% | -23.74% | -23.72% |
| Cost of Goods Sold | 8.36K | 18.22K | 45.12K | 290.63K | 196.92K | 152.97K | 349.98K | 406.3K | 97.87K | 159.76K | 120.14K | 153.44K |
| COGS % of Revenue | 230.96% | 679.38% | 40.9% | 47.52% | 56.96% | 54.88% | 83.4% | 121.27% | 14.46% | 32.6% | 50.08% | 42.21% |
| Gross Profit | -4.74K | -15.54K | 65.19K | 320.96K | 148.77K | 125.75K | 69.67K | -71.26K | 578.76K | 330.35K | 119.76K | 210.03K |
| Gross Margin % | -130.96% | -579.38% | 59.1% | 52.48% | 43.04% | 45.12% | 16.6% | -21.27% | 85.54% | 67.4% | 49.92% | 57.79% |
| Gross Profit Growth % | -103.18% | -112.36% | -6.42% | 550.38% | -74.3% | -61.93% | -41.83% | -133.93% | 66.46% | 39.08% | -41.62% | -38.27% |
| Operating Expenses | 3.28M | 2.64M | 2.35M | 2.44M | 2.46M | 3.31M | 4.31M | 3.43M | 3.32M | 4.29M | 3.58M | 8.17M |
| OpEx % of Revenue | 90523.11% | 98595.41% | 2132.39% | 399.72% | 712.42% | 1189.36% | 1026.21% | 1025.18% | 490.34% | 875.23% | 1494.3% | 2248.71% |
| Selling, General & Admin | 2.75M | 2.14M | 1.83M | 1.78M | 1.83M | 2.42M | 2.85M | 2.18M | 2.46M | 2.91M | 2.49M | 3.29M |
| SG&A % of Revenue | 75914.01% | 79963.24% | 1660.62% | 291.46% | 529.19% | 868.83% | 679.78% | 650.65% | 364.2% | 594.31% | 1038.87% | 904.35% |
| Research & Development | 0 | 499.71K | 520.41K | 25.99K | 0 | 0 | 0 | 33.46K | 0 | 0 | 0 | 203.56K |
| R&D % of Revenue | - | 18632.18% | 471.77% | 4.25% | - | - | - | 9.99% | - | - | - | 56% |
| Other Operating Expenses | 528.56K | 0 | 0 | 636.12K | 633.42K | 893.39K | 1000K | 1000K | 853.51K | 1000K | 1000K | 1000K |
| Operating Income | -3.28M | -2.66M | -2.29M | -2.12M | -2.31M | -3.19M | -4.24M | -3.51M | -2.74M | -3.96M | -3.46M | -7.96M |
| Operating Margin % | -90654.06% | -99174.79% | -2073.29% | -347.24% | -669.39% | -1144.24% | -1009.61% | -1046.45% | -404.8% | -807.82% | -1444.37% | -2190.93% |
| Operating Income Growth % | -41.74% | 16.6% | 46.02% | 39.43% | 15.52% | 19.45% | -22.27% | 55.97% | 33.69% | 62.38% | -1.49% | 6.96% |
| EBITDA | -3.25M | -2.49M | -2.12M | -1.55M | -2.27M | -3.03M | -4.07M | -3.35M | -2.58M | -3.78M | -3.23M | -7.63M |
| EBITDA Margin % | -89752.68% | -92826.73% | -1922.75% | -253.44% | -657.62% | -1085.34% | -970.87% | -999.19% | -380.71% | -771.07% | -1345.23% | -2099.4% |
| EBITDA Growth % | -42.84% | 17.7% | 47.94% | 53.7% | 11.75% | 19.95% | -26.25% | 56.13% | 32.21% | 62.95% | -4.42% | 6.82% |
| D&A (Non-Cash Add-back) | 32.61K | 170.25K | 166.07K | 573.64K | 40.67K | 164.16K | 162.56K | 158.34K | 162.99K | 180.13K | 237.85K | 332.69K |
| EBIT | -77.65M | -1.98M | -2.29M | -2.12M | -2.31M | -3.19M | -4.24M | -3.51M | -2.74M | -3.8M | -3.46M | -4.43M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 47.84K | 28.55K | -793.11K | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 47.84K | 28.55K | 42.23K | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 835.34K | 0 |
| Other Income/Expense | -74.37M | 680.97K | 1.63K | 22.79K | 30.56K | 7.99K | 672.67K | 513.78K | -9.37K | 35.86K | 43.18K | 47.32K |
| Pretax Income | -77.65M | -1.98M | -2.29M | -2.1M | -2.28M | -3.18M | -3.56M | -2.99M | -2.75M | -3.92M | -3.42M | -7.92M |
| Pretax Margin % | -2146123.19% | -73784.3% | -2071.81% | -343.51% | -660.55% | -1141.37% | -849.31% | -893.1% | -406.19% | -800.51% | -1426.37% | -2177.91% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -77.65M | -2.07M | -2.44M | -2.17M | -3.09M | -3.18M | -4.22M | -3.48M | -3.16M | -3.92M | -3.42M | -7.92M |
| Net Margin % | -2146264.32% | -77198.43% | -2214.55% | -354.75% | -895.23% | -1141.37% | -1005.33% | -1037.32% | -467.53% | -800.51% | -1426.37% | -2177.91% |
| Net Income Growth % | -2409.2% | 34.92% | 42.1% | 37.57% | 2.17% | 18.92% | -23.29% | 56.1% | 22.07% | 62.24% | -1.52% | -2.06% |
| Net Income (Continuing) | -77.65M | -1.98M | -2.29M | -2.1M | -2.28M | -3.18M | -3.56M | -2.99M | -2.75M | -3.92M | -3.42M | -7.92M |
| Discontinued Operations | -5.11K | -91.57K | -157.46K | -68.73K | -811.28K | -724.59K | -654.74K | -483.18K | -415.08K | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -107.25 | -0.23 | -0.34 | -0.40 | -0.48 | -0.68 | -1.04 | -0.86 | -0.78 | -0.98 | -0.86 | -2.01 |
| EPS Growth % | -22059.09% | 66.28% | 67.14% | 53.47% | 38.32% | 30.55% | -20.5% | 57.47% | 24.26% | 66.08% | 15.82% | 14.85% |
| EPS (Basic) | -107.25 | -0.23 | -0.34 | -0.40 | -0.61 | -0.68 | -1.04 | -0.86 | -0.68 | -0.98 | -0.86 | -2.01 |
| Diluted Shares Outstanding | 724K | 9.11M | 7.15M | 5.45M | 6.4M | 4.66M | 4.06M | 4.06M | 4.03M | 4M | 3.97M | 3.94M |
| Basic Shares Outstanding | 724K | 9.11M | 7.15M | 5.45M | 5.06M | 4.66M | 4.06M | 4.06M | 4.64M | 4M | 3.97M | 3.94M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |